More on AHKSY
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $20.98 |
|
|||
| Open | $20.98 | ||||
| 52 Wk High | $18.74 | ||||
| 52 Wk Low | $11.15 | ||||
| Day High | $20.98 | ||||
| Day Low | $20.98 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 18,029 | ||||
- Asahi Kasei licenses battery electrolyte technology to China's HighChem
- Asahi Kasei Enters First License Agreement for Production and Sale of Acetolyte™ Novel Electrolyte in China
- Asahi Kasei Microdevices Begins Mass Production of Camera‑less Modules for Detection of Falls, Vital Signs, Posture, and Position
- Asahi Kasei Adds New Slitting Facility for SUNFORT™ to Meet Growing Demand for Advanced Semiconductor Packaging
- Asahi Kasei’s Novel Forward Osmosis–Membrane Distillation System Installed at Peptistar's API Manufacturing Facility for Reduced Pharmaceutical Manufacturing Time
- Asahi Kasei Corp. (3407:JP) (AHKSY) PT Raised to JPY1,740 at Nomura/Instinet
- Veloxis Pharmaceuticals Showcases Research at the 2026 American Transplant Congress
- EAS Batteries Starts Sales of Ultra-High-Power Cell Using Asahi Kasei’s Novel Electrolyte Acetolyte™
- ZOLL® Expands “Anything Can Happen. Anyone Can Help.”™ to Strengthen Cardiac Emergency Readiness Across Youth Sports Nationwide
- Asahi Kasei Life Science licenses antibody-drug conjugate technology
Entities mentioned with AHKSY
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- S1 | View Related Stories »
- JPMorgan | View Related Stories »
- Goldman Sachs | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
